Cytorex Biosciences

Cytorex Biosciences is a Biopharma company with US patented technology to treat cancer using inorganic acids as actives.

Cytorex Biosciences is a Florida-based Biopharma company with a patented technology (US Patent 7,1412,51) to treat cancer using an approach that has never been taken before: Inorganic Acids as actives. Its lead compound is called Cytoreg, which is a combination of 4 inorganic acids and 2 organic acids in water, where The Fluoride (F- ion) of Hydrofluoric acid is the active agent. Cytoreg will target and kill cancer cells without affecting normal cells, hence becoming a very effective and safe product to administer to human cancer patients. The first indication for Cytoreg is Glioblastoma Multiforme, a malingnant brain tumor with a very low cure rate. Cytoreg can cross the blood brain barrier due to its very low molecular weight.